Androgen and gonadotropin patterns differ in HIV‐1‐infected men who develop lipoatrophy during antiretroviral therapy: a case–control study
Authors:
- M CavassiniMCM Cavassini
- H FurrerHFH Furrer
- the Swiss HIV Cohort StudyTSthe Swiss HIV Cohort Study
Open Access
- 8 July 2008
- journal article
- Published by Wiley in HIV Medicine
- Vol. 9 (6) , 427-432
Abstract
Objectives: We compared androgen and gonadotropin values in HIV‐infected men who did and did not develop lipoatrophy on combination antiretroviral therapy (cART).Methods: From a population of 136 treatment‐naïve male Caucasians under successful zidovudine/lamivudine‐based cART, the 10 patients developing lipoatrophy (cases) were compared with 87 randomly chosen controls. Plasma levels of free testosterone (fT), dehydroepiandrosterone (DHEA), follicle‐stimulating hormone and luteinizing hormone (LH) were measured at baseline and after 2 years of cART.Results: At baseline, 60% of the cases and 71% of the controls showed abnormally low fT values. LH levels were normal or low in 67 and 94% of the patients, respectively, indicating a disturbance of the hypothalamic–pituitary–gonadal axis. fT levels did not significantly change after 2 years of cART. Cases showed a significant increase in LH levels, while controls showed a significant increase in DHEA levels. In a multivariate logistic regression model, lipoatrophy was associated with higher baseline DHEA levels (P=0.04), an increase in LH levels during cART (P=0.001), a lower body mass index and greater age.Conclusions: Hypogonadism is present in the majority of HIV‐infected patients. The development of cART‐related lipoatrophy is associated with an increase in LH and a lack of increase in DHEA levels.Keywords
This publication has 29 references indexed in Scilit:
- A Randomized, Placebo‐Controlled Trial of Rosiglitazone for HIV‐Related LipoatrophyThe Journal of Infectious Diseases, 2007
- Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophyEuropean Journal of Pharmacology, 2006
- Are published normal ranges of serum testosterone too high? Results of a cross‐sectional survey of serum testosterone and luteinizing hormone in healthy menBJU International, 2004
- Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophyAIDS, 2003
- Diagnosis and Treatment of Androgen Deficiency in Human Immunodeficiency Virus–Infected Men and WomenClinical Infectious Diseases, 2001
- Prevalence of Hypogonadism among Men with Weight Loss Related to Human Immunodeficiency Virus Infection Who Were Receiving Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2000
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- A Close Association between Insulin Resistance and Dehydroepiandrosterone Sulfate in Subjects with Essential Hypertension.Endocrine Journal, 1999
- Endocrine function in 98 HIV-infected patientsAIDS, 1991
- Endocrine disorders in men infected with human immunodeficiency virusThe American Journal of Medicine, 1988